Cargando…
Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
Ipsilateral avid axillary lymph node uptake at FDG PET/CT persists in 29% (49 of 169) of patients between 7 to 10 weeks after the second dose of the mRNA-based BNT162b2 COVID-19 vaccination.
Autores principales: | Eshet, Yael, Tau, Noam, Alhoubani, Yousef, Kanana, Nayroz, Domachevsky, Liran, Eifer, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radiological Society of North America
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082565/ https://www.ncbi.nlm.nih.gov/pubmed/33904778 http://dx.doi.org/10.1148/radiol.2021210886 |
Ejemplares similares
-
COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake
por: Eifer, Michal, et al.
Publicado: (2022) -
FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study
por: Eifer, Michal, et al.
Publicado: (2022) -
Imaging of COVID-19 Vaccination at FDG PET/CT
por: Eifer, Michal, et al.
Publicado: (2021) -
Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability
por: Domachevsky, Liran, et al.
Publicado: (2017) -
The Utility of 68Ga-PSMA PET/CT in Decisions Regarding Administering Salvage Radiotherapy to Men with Prostate Cancer
por: Ben Shimol, Jennifer, et al.
Publicado: (2022)